BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • steve-wong.bmp

    Steven Wong, M.D.
    Assistant Professor of Medicine
    UCLA Medical Center

    Dr. Wong is an assistant professor of medicine in the division of hematology oncology at the UCLA Medical Center. He received his medical degree from UCLA School of Medicine, and completed his internship and residency at UCLA.  Dr. Wong also was a fellow in medical oncology at UCLA.

    Dr. Wong has been  involved in the important research study in breast cancer identifying the her2 gene as an important molecule in the pathogenesis of some breast cancers. This ultimately led to a new treatment called Herceptin which has made a dramatic improvement in the quality of life as well as survival in those pts with her2 metastatic breast cancer.

    Dr. Wong now focuses a large portion of his practice and research in genitourinary malignancies including bladder, testes and prostate. He attends numerous genitourinary cancer conferences and interacts with leaders worldwide. He is actively involved in research studying bladder cancer cell lines to better understand heterogeneity as well identifying new treatment targets. Dr. Wong participates in many of the clinical research studies at UCLA and is project investigator and subinvestigator for majority of the clinical studies.
    For more information about Dr. Wong, click here.